The largest database of trusted experimental protocols

5 protocols using ab233434

1

Immunohistochemical Analysis of PGAM5 and Parkin

Check if the same lab product or an alternative is used in the 5 most similar protocols
Typical CRC tissues and normal colorectal mucosal tissues were selected. The paraffin-embedded tissues were cut into 4-μm thick sections, dewaxed using xylene, rehydrated through gradient ethanol, and then heated using a pressure-cooker for antigen retrieval. Antigenic repair was performed with citric acid or repair solution, and endogenous peroxidase blocked with 3% H2O2-methanol (prepared with 30% H2O2 10 mL + methanol 90 mL). The sections were then incubated overnight at 4 °C with the following primary antibodies: Rabbit polyclonal anti-PGAM5 (1:200 dilution, ab126534; Abcam, United Kingdom) and rabbit polyclonal anti-Parkin (1:400 dilution, ab233434; Abcam, United Kingdom). Subsequently, sections were incubated with the secondary antibody for 40 min at 37 °C. Next, after washing in phosphate-buffered saline, the sections were stained with diaminobenzidine and then counter-stained with hematoxylin. The sections were then air-dried, dehydrated, and mounted. CRC tissues with intense immunoreactivity to PGAM5 and Parkin were used as positive controls; in the negative control, the primary antibody was replaced with phosphate-buffered saline.
+ Open protocol
+ Expand
2

Colorectal Cancer Protein Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Protein was extracted from the six matched pairs of colorectal adenocarcinoms and corresponding paracancerous tissues with the RIPA lysis buffer containing PMSF protease inhibitors and was quantified by using the BCA assay (Beyotime Institute of Biotechnology, China). Samples of 50 μg of protein were loaded and resolved by SDS-PAGE followed by transfer to a PVDF membrane. Non-specific binding was blocked using 5% bovine serum albumin in Tris Buffered Saline with Tween 20 (TBS-T, pH 7.6) for 2 h. Subsequently, incubation with primary antibodies, rabbit polyclonal anti-PGAM5 (1:1000 dilution, ab126534; Abcam, United Kingdom), rabbit polyclonal anti-Parkin (1:1000 dilution, ab233434; Abcam, United Kingdom), and glyceraldehyde-3-phosphate dehydrogenase (glyceraldehyde-3-phosphate dehydrogenase, 1:1000 dilution, FL-335; Santa Cruz Biotechnology, CA, United States) was undertaken overnight at 4 °C. After extensive washing, the membranes were incubated with anti-rabbit IgG secondary antibody (1:5000) and the immunoreactive bands were detected with ECL-Plus chemiluminescent detection HRP reagents (Beyotime Institute of Biotechnology, China) using the Microchemi 4.2 Bio-imaging system. The Western blots were quantified by densitometric analysis using ImageJ software (Version 1.46r). The experiments were repeated three times under the same experimental conditions.
+ Open protocol
+ Expand
3

Protein Extraction and Western Blot Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total proteins from tissues and cells were isolated by RIPA lysis buffer. The protein concentration was determined by BCA (Beyotime, P0012). Proteins (40 μg per lane) were loaded in sodium dodecyl sulfate–polyacrylamide gel electrophoresis and then transferred onto polyvinylidene difluoride (PVDF) membranes. PDFV membranes were blocked with nonfat milk and incubated with primary antibodies against GAPDH (Abcam, ab9485), LC3 (Cell Signaling Technology, 2775), PINK1 (Abcam, ab23707), and Parkin (Abcam, ab233434). The primary antibody was incubated overnight at 4°C and combined with the secondary antibody (Abcam, ab205718).
+ Open protocol
+ Expand
4

Immunofluorescence analysis of Parkin and mitophagy

Check if the same lab product or an alternative is used in the 5 most similar protocols
Oocytes were fixed in 4% paraformaldehyde for 30 min, washed 3 times with 0.1% Tween-20 and transferred to 0.1% Triton X-100 overnight for permeabilization. Permeabilized oocytes were washed 3 times and then blocked with 1% BSA for 1 h.
Blocked oocytes were successively incubated with the primary and secondary antibodies Rabbit anti-Parkin antibody (ab233434, Abcam, Boston, MA, USA) and Goat anti-rabbit IgG H&L (Alexa Fluor® 647) (ab150079, Abcam, USA), washed with PBS 3 times and the fluorescence aggregation of Parkin was observed with LSCM.
For colocalization of LC3B and TOMM20, blocked oocytes were incubated with Rabbit Anti-LC3B (ab192890, Abcam, USA) and Mouse Anti-TOMM20 (ab283317, Abcam, USA) for 1 h, then incubated with secondary antibodies Goat anti-mouse IgG H&L (Alexa Fluor® 488) (ab150113, Abcam, USA) and Goat anti-rabbit IgG H&L (Alexa Fluor® 647) (ab150079, Abcam, USA), washed with PBS 3 times and observed with LSCM. The overlapping coefficient was analyzed using Image J as the fraction of VDAC1 overlapping LC3B.
+ Open protocol
+ Expand
5

Protein Expression Analysis in Oocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
For protein extraction, 100 oocytes were gathered and transferred in protein lysis buffer as a sample, with three duplicates for each group and the determination of protein concentration was performed using a BCA Protein Assay Kit (02912E, Cwbiotech, Beijing, China). Western blotting assay was subsequently performed following manufacturers’ protocols to ensure the levels of protein expression. The information of primary and secondary antibodies is listed as follows: Rabbit Anti-PINK1 (ab23707, Abcam, USA), Rabbit anti-Parkin (ab233434, Abcam, USA), Rabbit Anti-VDAC1/Porin (ab15895, Abcam, USA), Rabbit anti-Mitofusin 2 (ab124773, Abcam, USA), Rabbit Anti-LC3B, Rabbit Anti-SQSTM1/p62 (ab233207, Abcam, USA), Rabbit Anti-GAPDH (ab9484, Abcam, USA) and the secondary antibody Goat anti-rabbit IgG (H+L) (HRP) (111-035-003, Jackson, West Grove, PA, USA). The expression of GAPDH was determined as a loading control.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!